PortfoliosLab logo

Allarity Therapeutics, Inc. (ALLR)

Equity · Currency in USD · Last updated Mar 18, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Allarity Therapeutics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $100 for a total return of roughly -99.00%. All prices are adjusted for splits and dividends.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%20.00%NovemberDecember2023FebruaryMarch
-90.46%
6.47%
ALLR (Allarity Therapeutics, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ALLR

Allarity Therapeutics, Inc.

Return

Allarity Therapeutics, Inc. had a return of -64.29% year-to-date (YTD) and -95.23% in the last 12 months. Over the past 10 years, Allarity Therapeutics, Inc. had an annualized return of -97.63%, outperforming the S&P 500 benchmark which had an annualized return of -13.01%.


PeriodReturnBenchmark
1 month-41.34%-5.31%
Year-To-Date-64.29%2.01%
6 months-91.67%0.39%
1 year-95.23%-10.12%
5 years (annualized)-97.63%-13.01%
10 years (annualized)-97.63%-13.01%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-14.97%-26.00%
2022-5.98%-49.09%-19.82%-34.52%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Allarity Therapeutics, Inc. Sharpe ratio is -0.72. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.90-0.80-0.70-0.60-0.50-0.40-0.30-0.20Dec 252023Jan 08Jan 15Jan 22Jan 29Feb 05Feb 12Feb 19Feb 26Mar 05Mar 12
-0.72
-0.43
ALLR (Allarity Therapeutics, Inc.)
Benchmark (^GSPC)

Dividend History


Allarity Therapeutics, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2023FebruaryMarch
-99.17%
-18.34%
ALLR (Allarity Therapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Allarity Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Allarity Therapeutics, Inc. is 99.17%, recorded on Mar 17, 2023. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.17%Dec 23, 2021309Mar 17, 2023

Volatility Chart

Current Allarity Therapeutics, Inc. volatility is 78.15%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%250.00%NovemberDecember2023FebruaryMarch
78.15%
21.17%
ALLR (Allarity Therapeutics, Inc.)
Benchmark (^GSPC)